bullish
Aier Eye Hospital Group (300015.CH) - The Concerns Behind the High Growth Momentum
224 Views28 Sep 2021 09:03
The article mainly analyzed Aier Eye Hospital in terms of its performance in 2021/1H and the concerns such as high acquisition premium, high goodwill balance,medical negligence and disputes and so on.
SUMMARY
(Sign Up to Access)Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
- Unlock all research summaries
- Follow top, independent analysts
- Receive personalised alerts and emails
- Access Briefings, Analytics, and Events
Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.
Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 5-minute read)
Discussions
(Paid Plans Only)
Top 5%
Xinyao (Criss) Wang
HK/China Healthcare Analyst (ex-Fosun Pharma)
- Hygeia Healthcare Group (6078.HK) 2021 Results - Solid Business Logic Comes with Policy Risk20 Apr 2022
- Pre IPO Ascent ENT Group Holdings - Conservative About the Outlook10 Mar 2022
- Aier Eye Hospital Group (300015.CH) - More than Just Bribery Scandal20 Jan 2022
- Aier Eye Hospital Group (300015.CH) - The Concerns Behind the High Growth Momentum28 Sep 2021
- China Healthcare Weekly (Sep.24) - VBP on Neuro-Intervention, Payment System Changes, AI in Drug R&D26 Sep 2021
- Presentation on Apr.12: 2021 High Conviction Ideas - Topchoice Medical (600763.CH)13 Apr 2021
- Aier Eye Hospital(300015.CH) - The Largest Ophthalmic Chain in China with Promising Growth Potential09 Dec 2020
x